Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 292-297 , September 2006

A simplified protocol to screen for distal polyneuropathy in type 2 diabetic patients

  • Luciana A. Costa

      Affiliations

    • Endocrine Division, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
  • ,
  • Jorge F. Maraschin

      Affiliations

    • Endocrine Division, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
  • ,
  • José H. Xavier de Castro

      Affiliations

    • Neurology Division, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
  • ,
  • Jorge L. Gross

      Affiliations

    • Endocrine Division, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
  • ,
  • Rogério Friedman

      Affiliations

    • Endocrine Division, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
    • Corresponding Author InformationCorresponding author at: Serviço de Endocrinologia, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2350, Prédio 12-4° andar, 90035-903 Porto Alegre, RS, Brazil. Tel.: +55 51 3332 5188; fax: +55 51 2101 8777.

Received 18 April 2005 ,Revised 21 January 2006 ,Accepted 7 February 2006.

References 

  1. Caputo GM, Cavanagh PR, Ulbrecht JS, Gibbons GW, Karchmer AW. Assessment and management of foot disease in patients with diabetes. N. Engl. J. Med. 1994;331:854–860
  2. Dyck PJ, Kratz KM, Karnes MS, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–824
  3. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diab. Metab. 1977;3:245–256
  4. Haimanot RT, Abdulkadir J. Neuropathy in Ethiopian diabetics: a correlation of clinical and nerve conduction studies. Trop. Geogr. Med. 1985;37:62–68
  5. American Diabetes Association, American Academy of Neurology, Consensus Statement, Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy, Diab. Care 11 (1988) 592–597.
  6. Thomas PK, Eliason SG. Diabetic neuropathy. In:  Dyck PJ,  Thomas PK,  Lambert EH,  Bunge R editor. Peripheral Neuropathy. Philadelphia: Saunders; 1984;p. 1773–1810
  7. Sullivan JF. The neuropathies of diabetes. Neurology. 1958;8:243–249
  8. Nyamu PN, Otieno CF, Amayo EO, McLigeyo SO. Risk factors and prevalence of diabetic foot ulcers at Kenyatta National Hospital, Nairobi. East Afr. Med. J. 2003;80(January (1)):36–43
  9. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower extremity amputation in people with diabetes: epidemiology and prevention. Diab. Care. 1989;12:24–31
  10. Division of Diabetes Translation (Diabetes Surveillance), Annual 1990 Report, Centers for Disease Control, Atlanta, GA, 1990.
  11. National Diabetes Advisory Board: The National Long-Range Plan to Combat Diabetes (DHHS Publication No. 87-1587), Washington, DC, US Government Printing Office, 1987, p. 87.
  12. Block P. The diabetic foot ulcer: a complex problem with a simple treatment approach. Mil. Med. 1981;146:644;(Letter)
  13. Smith DM, Weinberger M, Katz BP. A controlled trial to increase office visits and reduce hospitalizations of diabetic patients. J. Gen. Intern. Med. 1987;2:232
  14. Waugh NR. Amputations in diabetic patients: a review of rates, relative risks, and resources use. Community Med. 1988;10:279
  15. Connor H. The economic impact of diabetic foot disease. In:  Connor H,  Boulton AJM,  Ward JD,  Chichester A editor. The Foot Diabetes. England: John Wiley and Sons; 1987;p. 145–149
  16. Dyck PJ, Davies JL, Litchy WJ, O’Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology. 1997;49:229–239
  17. Arezzo JC. New developments in the diagnosis of diabetic neuropathy. Am. J. Med. 1999;107(2B):9S–16S
  18. Donaghue VM, Giurini JM, Rosenblum BI, Weissman PN, Veves A. Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. Diab. Res. Clin. Pract. 1995;29(1):37–42
  19. Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Uusitupa M, Sonksen PH. A multicenter study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–154
  20. Dyck PJ, Karnes JL, Daube J, O’Brain PC, Service FJ. Clinical and neuropathological criteria for the diagnosis and staging of diabetic neuropathy. Brain. 1985;108:861–880
  21. Dyck PF, Kratz KM, Karnes MS, Melton P, O’Brain PC, Litchy WJ, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology. 1991;41:799–807
  22. Dyck PJ, Karnes JL, O’Brian PC, Swanson CJ. Neuropathy symptom profile in health, motor neuron disease, diabetic neuropathy and amyloidosis. Neurology. 1986;36:1300–1308
  23. Albers JW, Brown MB, Sima AAF, Greene DA. The Tolrestat Study Group for the early diabetes intervention trial. Nerve conduction measures in mild diabetic neuropathy in the early diabetes intervention trial: the effects of age, sex, type of diabetes, duration, and anthropometric factors. Neurology. 1996;46:85–91
  24. American Diabetes Association Diagnosis and Classification of Diabetes Mellitus, Diab. Care 28 (Suppl. 1) (2005).
  25. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V), Arch. Intern. Med. (1993) 154–183.
  26. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diab. Care. 2004;27(6):1438–1486
  27. Herman W, Hawthorne V, Hamman R, Keen H, DeFronzo R, Newman J, et al. Proceedings from the international symposium on preventing the kidney disease of diabetes mellitus: public health perspectives—consensus statement. Am. J. Kidney Dis. 1989;13:2–6
  28. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br. Med. J. 1982;285:916–918
  29. Gentile S, Turco S, Corigliano G, Marmo F The S.I.M.S.D.N Group. Simplified diagnostic criteria for distal polyneuropathy. Preliminary data of a multicentre study in the Campania region. Acta Diabetol. 1995;32:7–12
  30. Carrington AL, Shaw JE, Van Schie CHM, Abbott CA, Vileikyte L, Boulton AJML. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?. Diab. Care. 2002;25:2010–2015
  31. Harris M, Eastman R, Cowie A. Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diab. Care. 1993;16:1446–1452
  32. Resnick HE, Stansberry KB, Harris TB, et al. Diabetes, peripheral neuropathy, and old age disability. Muscle Nerve. 2002;25:43–50

PII: S0168-8227(06)00059-3

doi: 10.1016/j.diabres.2006.02.005

Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 292-297 , September 2006